Bundamedik Tbk Pt Stock Five Year Return
BMHS Stock | 268.00 2.00 0.74% |
Bundamedik Tbk PT fundamentals help investors to digest information that contributes to Bundamedik Tbk's financial success or failures. It also enables traders to predict the movement of Bundamedik Stock. The fundamental analysis module provides a way to measure Bundamedik Tbk's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bundamedik Tbk stock.
Bundamedik |
Bundamedik Tbk PT Company Five Year Return Analysis
Bundamedik Tbk's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition |
According to the company disclosure, Bundamedik Tbk PT has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Medical Care Facilities (which currently averages 0.0) industry. This indicator is about the same for all Indonesia stocks average (which is currently at 0.0).
Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
All Next | Launch Module |
Bundamedik Fundamentals
Return On Equity | 0.0811 | |||
Return On Asset | 0.0465 | |||
Profit Margin | 0.06 % | |||
Operating Margin | 0.13 % | |||
Current Valuation | 3.68 T | |||
Shares Outstanding | 8.6 B | |||
Shares Owned By Insiders | 78.80 % | |||
Price To Book | 2.14 X | |||
Price To Sales | 2.17 X | |||
Revenue | 1.71 T | |||
Gross Profit | 799.78 B | |||
EBITDA | 291.45 B | |||
Net Income | 215.3 B | |||
Total Debt | 225.96 B | |||
Book Value Per Share | 186.41 X | |||
Cash Flow From Operations | 260.04 B | |||
Earnings Per Share | 30.71 X | |||
Target Price | 855.0 | |||
Number Of Employees | 1.16 K | |||
Market Capitalization | 3.61 T | |||
Total Asset | 2.69 T | |||
Z Score | 9.0 | |||
Annual Yield | 0.01 % | |||
Net Asset | 2.69 T | |||
Last Dividend Paid | 2.56 |
About Bundamedik Tbk Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bundamedik Tbk PT's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bundamedik Tbk using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bundamedik Tbk PT based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Bundamedik Stock
Bundamedik Tbk financial ratios help investors to determine whether Bundamedik Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bundamedik with respect to the benefits of owning Bundamedik Tbk security.